Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 21 open reading frame 59 pseudogene (C21orf59P, ENSG00000270727) is a nonfunctional genomic DNA sequence located on human chromosome 21 that closely resembles a protein-coding gene but contains disabling mutations such as frameshifts or premature stop codons, preventing production of a functional protein product[1][2][4]. Pseudogenes like this commonly arise from gene duplication or retrotransposition events, and while the majority are biologically inert, some may rarely give rise to regulatory RNA transcripts, but there is currently no evidence that C21orf59P fulfills such a role[4][6]. This pseudogene is not known to be involved in any disease, is not a therapeutic target, does not interact with drugs, and is not used as a biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 21 open reading frame 59 pseudogene (C21orf59P).